As scrutiny of pharmaceutical pricing intensifies, excessive pricing is emerging as a tangible enforcement risk within European competition law. Using the AbbVie v. PAF case in the Netherlands as a case study, this presentation explores how courts and authorities are reassessing pricing conduct and what this means for your future strategy.
Alex Eichner
Senior Director Legal & Regulatory Europe
IPD Analytics
Alexander Eichner is a Senior Director of European Legal & Regulatory Analysis at IPD Analytics. He observes, analyses, and predicts EPO oppositions and appeals, national court proceedings, and UPC hearings, and coordinates IPD’s coverage of these disputes across Europe and globally. He also analyses IP portfolios in the pharmaceutical, biotech, and medtech sectors and contributes to the development of new legal and insights products.
Before joining IPD Analytics in 2021, he spent seven years at top-tier Munich patent law firms specializing in biotechnology. He is a qualified European and German Patent Attorney and a registered UPC Representative. He holds a BSc and MSc in Biochemistry from the Technical University of Munich and a doctorate based on research conducted at the Institute of Science and Technology Austria.
Joshua Bleet
Executive VP of International Legal & Regulatory Analysis
IPD Analytics
Joshua Bleet is the Executive Vice President of International Legal & Regulatory Analysis at IPD Analytics. Joshua joined IPD 17 years ago after working as a patent litigator and clerking for Judge Alvin A. Schall of the U.S. Court of Appeals for the Federal Circuit. He leads a team of attorneys who observe, analyze, and predict court and patent office proceedings in Europe (EPO, national courts, UPC), Japan, China, India, Canada, Australia, Korea, Brazil, Russia, Mexico, and Taiwan). He also leads teams dedicated to Global Litigation Tracking, Expert Witness Insights, Settlement Analytics, and Claim Construction Insights. Previously, Joshua led IPD’s development of the European Supplementary Protection Certificate Tracker. His favorite part of the job is solving problems thought to be unsolvable.
Charmain Simmons
Financial Crime and Compliance Expert
SymphonyAI
Charmian Simmons
Principle Strategic Advisor, FinCrime Compliance
SymphonyAI
Charmian Simmons is a Principal Strategic Advisor for FinCrime Compliance, helping financial institutions navigate the evolving intersection of regulation, risk, technology and innovation. She has over 20 years of experience in the financial sector across risk management, financial crime, internal controls and IT advisory. A technology evangelist with a focus on AI-driven innovation and transformation, Charmian leverages her practitioner expertise and industry knowledge to provide strategic advisory services and thought leadership on the regulatory, policy and technology developments transforming financial crime compliance.
Prior to joining Symphony AI, Charmian was a FinCrime Expert with BAE Systems, a Regional Director of Strategy and Performance for the Risk business at Refinitiv, the Head of Audit in North America at Lloyds Banking Group USA and a Vice President at Morgan Stanley covering Capital Markets. Charmian is CAMS, CDPSE, CRMA and CISA certified.
Caroline Brown
Partner
Deloitte
Ramesh Panavalli
Head of Responsible Sourcing & Human Rights
Holland & Barrett
Fergal Brady
Patent Examiner
Intellectual Property Office of Ireland
Dylan Saunders
Senior Account Executive
Regrow Ag
Dylan Saunders works at Regrow Ag, supporting the development of data-driven solutions that help build more resilient and sustainable agricultural systems. With a background from the University of Colorado Boulder, he focuses on applying technology to drive measurable impact across global supply chains. When he's not working, you can find Dylan on a trail with his cattle dog, Rosie.
Richard Page
Partner
df-mp
Richard Page is a European Patent Attorney and a UPC Representative, specialising in life science patents. Drawing on his solid technical background as a researcher in the UK and Germany and fourteen years of IP experience, he advises clients across a broad range of life science technologies. He has particular expertise in antibody-related inventions, vaccines and second medical uses. Richard has a strong track record in opposition and appeal proceedings before the European Patent Office, and he brings his contentious insights into his drafting and prosecution work to help clients secure strategically robust and commercially valuable patent protection.